Guide · 6 min · 2026-07-23
Controlled print and issuance: what auditors ask
How pharmaceutical teams should think about controlled copies, issuance registers, recall, and training awareness before print—without vendor name-dropping.
Why print still matters
Even digital-first plants print for floors that need paper. Auditors ask who got which copy, whether it was current, and what happened when a revision landed.
Issuance you can explain
Copy numbering, registers, and recall workflows should be visible—not a notebook in a drawer. If someone cannot show where a copy went, findings follow.
Training before view or print
Critical documents often require competency before secure view or print. Informal floor clearances fail when inspectors ask for evidence.
Security people can see
Watermarks and other copy protections help—but only alongside governance. Technology without process still fails audit conversations.
How Novaqis approaches it
Novaqis DMS ties controlled issuance and training-aware access into the same document story. See Document security and Pharma DMS solution pages for the product view.
Ready to see Novaqis on your terms?
We prefer live walkthroughs over generic slides. Ask for a demo or a tailored quote—no published list prices.